{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:04:03Z","timestamp":1790309043400,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.ejca.2012.10.008","type":"journal-article","created":{"date-parts":[[2012,11,11]],"date-time":"2012-11-11T09:51:27Z","timestamp":1352627487000},"page":"1065-1072","source":"Crossref","is-referenced-by-count":20,"title":["Weekly topotecan and cisplatin (TOPOCIS) as neo-adjuvant chemotherapy for locally-advanced squamous cervical carcinoma: Results of a phase II multicentric study"],"prefix":"10.1016","volume":"49","author":[{"given":"F.","family":"Zanaboni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Grijuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Giudici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Cormio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Babilonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ghezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Giorda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Franchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lorusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ditto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Lorusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Raspagliesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejca.2012.10.008_b0005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.ejca.2012.10.008_b0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1200\/JCO.20.1.179","article-title":"Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study","volume":"20","author":"Benedetti-Panici","year":"2002","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2012.10.008_b0015","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1200\/JCO.2000.18.8.1740","article-title":"Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer","volume":"18","author":"Chang","year":"2000","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2012.10.008_b0020","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00000421-199606000-00009","article-title":"The role of neoadjuvant intraarterial infusion chemotherapy with cisplatin and bleomycin for locally advanced cervical cancer","volume":"19","author":"Kigawa","year":"1996","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2012.10.008_b0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1006\/gyno.1997.4812","article-title":"Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results","volume":"67","author":"Sardi","year":"1997","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2012.10.008_b0030","first-page":"CD001774","article-title":"Neoadjuvant chemotherapy for locally advanced cervix cancer","author":"Neoadjuvant Chemotherapy for Cervical Cancer Meta-Analysis Collaboration (NACCCMA) Collaboration","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ejca.2012.10.008_b0035","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1023\/A:1011117617514","article-title":"A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma","volume":"12","author":"Duenas-Gonzalez","year":"2001","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2012.10.008_b0040","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1023\/A:1008461408626","article-title":"Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer","volume":"9","author":"Zanetta","year":"1998","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2012.10.008_b0045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.bjc.6690656","article-title":"Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer","volume":"81","author":"Sugiyama","year":"1999","journal-title":"Br J Cancer"},{"issue":"18","key":"10.1016\/j.ejca.2012.10.008_b0050","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1200\/JCO.2005.04.172","volume":"23","author":"Buda","year":"2005","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2012.10.008_b0055","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ygyno.2007.04.007","article-title":"Treatment of (\u201cbulky\u201d) stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic\/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group","volume":"106","author":"Eddy","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2012.10.008_b0060","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ygyno.2006.07.006","article-title":"Phase II study of neoadjuvant chemotherapy with mitomycin-c, vincristine and cisplatin (MVC) in patients with stages IB2-IIB cervical carcinoma","volume":"104","author":"Choi","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2012.10.008_b0065","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s002800050755","article-title":"In vitro and in vivo interaction between cisplatin and topotecan in ovarian carcinoma systems","volume":"41","author":"Romanelli","year":"1998","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3 Pt. 2","key":"10.1016\/j.ejca.2012.10.008_b0070","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S0090-8258(03)00465-7","article-title":"The role of topotecan in the treatment of advanced cervical cancer","volume":"90","author":"Fiorica","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2012.10.008_b0075","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/gyno.2001.6557","article-title":"Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix","volume":"85","author":"Fiorica","year":"2002","journal-title":"Gynecol Oncol"},{"issue":"21","key":"10.1016\/j.ejca.2012.10.008_b0080","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1200\/JCO.2005.10.021","article-title":"Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study","volume":"23","author":"Long","year":"2005","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.ejca.2012.10.008_b0085","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1200\/JCO.1996.14.12.3056","article-title":"Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II study","volume":"14","author":"Creemers","year":"1996","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2012.10.008_b0090","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1200\/JCO.1999.17.2.658","article-title":"Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer","volume":"17","author":"von Pawel","year":"1999","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2012.10.008_b0095","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1200\/JCO.1992.10.4.647","article-title":"Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor","volume":"10","author":"Rowinsky","year":"1992","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2012.10.008_b0100","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ygyno.2011.04.013","article-title":"A prospective phase II study of topotecan (Hycamtin\u00ae) and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer","volume":"122","author":"Manci","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2012.10.008_b0105","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1006\/gyno.2001.6435","article-title":"A dose-escalating study of weekly bolus topotecan in previously treated ovarian cancer patients","volume":"83","author":"Homesley","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2012.10.008_b0110","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ygyno.2004.08.026","article-title":"Retrospective analysis of weekly topotecan as salvage therapy in relapsed ovarian cancer","volume":"95","author":"Bhoola","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2012.10.008_b0115","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.ygyno.2004.09.005","article-title":"Phase II study of weekly topotecan in patients with recurrent or persistent epithelial ovarian cancer","volume":"95","author":"Levy","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2012.10.008_b0120","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ygyno.2005.04.032","article-title":"Weekly topotecan in heavily pretreated patients with recurrent epithelial ovarian carcinoma","volume":"98","author":"O\u2019Malley","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2012.10.008_b0125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ygyno.2007.08.062","article-title":"Weekly topotecan for recurrent platinum resistant ovarian cancer","volume":"108","author":"Abushahin","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"Suppl. 6","key":"10.1016\/j.ejca.2012.10.008_b0130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1634\/theoncologist.9-90006-25","article-title":"Emerging role of weekly topotecan in recurrent small cell lung cancer","volume":"9","author":"Eckardt","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/j.ejca.2012.10.008_b0135","unstructured":"Common Terminology Criteria for Adverse Events v3.0 (CTCAE). NCI; 2003."},{"key":"10.1016\/j.ejca.2012.10.008_b0140","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.ejca.2012.10.008_b0145","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(08)70074-3","article-title":"Classification of radical hysterectomy","volume":"9","author":"Querleu","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2012.10.008_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","article-title":"Optimal two-stage designs for phase II clinical trials","volume":"10","author":"Simon","year":"1989","journal-title":"Control Clin Trials"},{"issue":"35","key":"10.1016\/j.ejca.2012.10.008_b0185","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1200\/JCO.2008.16.4368","article-title":"Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta analysis of individual patient data from 18 randomized trials","volume":"26","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2012.10.008_b0190","first-page":"CD007406","article-title":"Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer","volume":"1","author":"Rydzewska","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ejca.2012.10.008_b0160","first-page":"92","article-title":"The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer","volume":"21","author":"Yin","year":"2011","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2012.10.008_b0165","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/annonc\/mdn690","volume":"20","author":"Lissoni","year":"2009","journal-title":"Ann Oncol"},{"issue":"21","key":"10.1016\/j.ejca.2012.10.008_b0170","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1200\/JCO.2005.10.522","article-title":"Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group Study","volume":"23","author":"Monk","year":"2005","journal-title":"J Clin Oncol"},{"issue":"11 Suppl. 2","key":"10.1016\/j.ejca.2012.10.008_b0175","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1111\/IGC.0b013e3181f967ed","article-title":"Critical review of neoadjuvant chemotherapy followed by surgery for locally advanced cervical cancer","volume":"20","author":"Colombo","year":"2010","journal-title":"Int J Gynecol Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804912008076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804912008076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T13:26:42Z","timestamp":1540128402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804912008076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0959804912008076"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2012.10.008","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}